Earnings GuidanceCVS lowered adjusted EPS guidance to >$8.30 from >$8.50, citing MA utilization pressure.
Health Care Benefits PerformanceThe Health Care Benefits (HCB) segment miss was driven by a higher than expected MLR due to continued elevated utilization trends in the Medicare Advantage (MA) business.
Medicare Advantage RatesThe effective rate decrease of -0.16% for the CY25 Medicare Advantage benchmark rate remains unchanged, which is below expectations for a 50-100bps improvement.